Literature DB >> 29334284

Surface endoglin (CD105) expression on acute leukemia blast cells: an extensive flow cytometry study of 1002 patients.

Vincenzo Cosimato1, Giulia Scalia1, Maddalena Raia1, Laura Gentile1, Vincenza Cerbone1, Feliciano Visconte1, Teodora Statuto2, Luciana Valvano2, Fiorella D'Auria2, Giovanni Calice2, Daniela Graziano3, Pellegrino Musto4, Luigi Del Vecchio1,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29334284     DOI: 10.1080/10428194.2017.1416366

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  6 in total

1.  Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin.

Authors:  Douglas G Walker; Lih-Fen Lue; Thomas G Beach; Ikuo Tooyama
Journal:  Cells       Date:  2019-07-23       Impact factor: 6.600

Review 2.  Endoglin: An 'Accessory' Receptor Regulating Blood Cell Development and Inflammation.

Authors:  Steffen K Meurer; Ralf Weiskirchen
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

3.  Impact of CD105 Flow-Cytometric Expression on Childhood B-Acute Lymphoblastic Leukemia.

Authors:  Rasha A Elkholy; Mohamed H Fouda; Eslam E Elhawary; Reem A Elkholy; Ola A Elshora
Journal:  J Blood Med       Date:  2021-03-16

4.  CD105 (Endoglin) as negative prognostic factor in AML.

Authors:  Joseph Kauer; Karolin Schwartz; Claudia Tandler; Clemens Hinterleitner; Malte Roerden; Gundram Jung; Helmut R Salih; Jonas S Heitmann; Melanie Märklin
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

5.  Therapeutic effect of TRC105 and decitabine combination in AML xenografts.

Authors:  June Baik; Martin Felices; Ashley Yingst; Charles P Theuer; Michael R Verneris; Jeffrey S Miller; Rita Perlingeiro
Journal:  Heliyon       Date:  2020-10-13

6.  Identification of CD105 (endoglin) as novel risk marker in CLL.

Authors:  Sarah M Greiner; Melanie Märklin; Samuel Holzmayer; Kübra Kaban; Sophie Meyer; Clemens Hinterleitner; Claudia Tandler; Ilona Hagelstein; Gundram Jung; Helmut R Salih; Jonas S Heitmann; Joseph Kauer
Journal:  Ann Hematol       Date:  2022-01-19       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.